or Try an Advanced Search...

    Adjunctive Therapy Stocks List

    Symbol Grade Name % Change
    SAGE F Sage Therapeutics, Inc. 1.83
    HURA F TuHURA Biosciences, Inc. -0.60
    CTSO F Cytosorbents Corporation -2.83
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Acute Respiratory Distress Syndrome Anticonvulsants Antidepressants Antineoplastic Drugs Biopharmaceutical Blood Plasma Blood Products Bypass Bypass Surgery Cancer Cancer Immunotherapy Cardiopulmonary Bypass Cardiopulmonary Bypass Surgery Central Nervous System Disorders Checkpoint Inhibitor Clinical Development Clinical Medicine Cytokine Disease Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Adjunctive Therapy stocks.

    Symbol Grade Name Weight
    PSIL C AdvisorShares Psychedelics ETF 4.78
    BBP C BioShares Biotechnology Products Fund 0.65
    BIS B ProShares UltraShort Nasdaq Biotechnology 0.48
    QQQS C Invesco NASDAQ Future Gen 200 ETF 0.33
    NIXT B Research Affiliates Deletions ETF 0.25
    View all Adjunctive Therapy ETFs...
    Compare ETFs
    Compare PSIL to BBP Compare PSIL to QQQS Compare QQQS to NIXT

        Adjunctive Therapy Stocks Recent News

        Date Stock Title
        Nov 21 SAGE Sage ends dalzanemdor development following Phase II trial failure
        Nov 21 SAGE SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study
        Nov 21 SAGE Sage raised to sector perform by RBC in wake of drug failure
        Nov 20 SAGE After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
        Nov 20 SAGE Sage slips as Huntington’s Disease therapy fails in mid-stage trial
        Nov 20 SAGE Sage’s string of research failures continues
        Nov 20 SAGE Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
        Nov 19 SAGE CNS Drug Development: Same As It Ever Was
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Acute Respiratory Distress Syndrome Anticonvulsants Antidepressants Antineoplastic Drugs Biopharmaceutical Blood Plasma Blood Products Bypass Bypass Surgery Cancer Cancer Immunotherapy Cardiopulmonary Bypass Cardiopulmonary Bypass Surgery Central Nervous System Disorders Checkpoint Inhibitor Clinical Development Clinical Medicine Cytokine Disease Drugs
        Adjunctive Therapy

        Adjunctive therapy is a type of treatment that is used in addition to the primary treatment for a medical condition. It is often used to help manage symptoms or side effects of the primary treatment, or to help improve the effectiveness of the primary treatment. Examples of adjunctive therapies include physical therapy, occupational therapy, speech therapy, and psychotherapy.

        Browse All Tags